Study: NCT02608320

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duragesic (Fentanyl TDS Large Patches)
Description: Duragesic 100 mcg/h (Treatment D) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duragesic (Fentanyl TDS Large Patches)
Description: Duragesic 100 mcg/h (Treatment D) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duragesic (Fentanyl TDS Large Patches)
Description: Duragesic 100 mcg/h (Treatment D) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duragesic (Fentanyl TDS Large Patches)
Description: Duragesic 100 mcg/h (Treatment D) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duragesic (Fentanyl TDS Large Patches)
Description: Duragesic 100 mcg/h (Treatment D) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: New JNJ-35685-AAA-G021 (Fentanyl TDS Large Patches)
Description: New JNJ-35685-AAA-G021 100 mcg/h (Treatment E) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: New JNJ-35685-AAA-G021 (Fentanyl TDS Large Patches)
Description: New JNJ-35685-AAA-G021 100 mcg/h (Treatment E) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: New JNJ-35685-AAA-G021 (Fentanyl TDS Large Patches)
Description: New JNJ-35685-AAA-G021 100 mcg/h (Treatment E) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: New JNJ-35685-AAA-G021 (Fentanyl TDS Large Patches)
Description: New JNJ-35685-AAA-G021 100 mcg/h (Treatment E) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: New JNJ-35685-AAA-G021 (Fentanyl TDS Large Patches)
Description: New JNJ-35685-AAA-G021 100 mcg/h (Treatment E) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: New JNJ-35685-AAA-G021 (Fentanyl TDS Large Patches)
Description: New JNJ-35685-AAA-G021 100 mcg/h (Treatment E) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: New JNJ-35685-AAA-G021 (Fentanyl TDS Large Patches)
Description: New JNJ-35685-AAA-G021 100 mcg/h (Treatment E) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.